Molecular Imaging Preview

Road to RSNA 2025: Molecular Imaging Preview
By Will Morton
The green flag is up, and nuclear medicine and molecular imaging have plenty of fuel in their tank on the 2025 Road to RSNA.
November 19, 2025
Road To Rsna
Different breast cancer treatments lead to varied effects on heart health
By Amerigo Allegretto
Session attendees will learn how different chemotherapy regimens affect myocardial accumulation in breast cancer patients.
November 19, 2025
Pentixafor PET/CT promising in patients with primary aldosteronism
By Will Morton
Ga-68 pentixafor PET/CT shows high accuracy in detecting aldosterone-producing adenomas in patients with primary aldosteronism.
November 19, 2025
New tracer may guide surgery in patients with PHPT
By Will Morton
PET/CT imaging with the radiotracer gallium-68 trivehexin offers high sensitivity for detecting hyperfunctioning parathyroid tissue.
November 19, 2025
PET identifies risk of adverse events in Lu-177 PSMA treatment
By Will Morton
Bone tumor volume is associated with adverse events in prostate cancer patients who received Lu-177 PSMA treatment, presenters say.
November 19, 2025
SPECT/CT predicts response to Lu-177 PSMA-617 treatment
By Will Morton
Lu-177 PSMA-617 benefits patients with metastatic castration-resistant prostate cancer, but individual outcomes vary.
November 19, 2025
PET identifies reduced brain activity in ALS patients
By Will Morton
F-18 FDG-PET/CT scans have linked reduced brain metabolism and survival in patients with amyotrophic lateral sclerosis (ALS).
November 19, 2025
ChatGPT handy for ICD-10 coding of PET/CT reports
By Will Morton
In centers that perform 30 PET/CT scans daily, ChatGPT could save clinicians an hour if used to assign ICD-10 codes to exam reports.
November 19, 2025
What’s the optimal scan time for F-18 SiTATE PET?
By Will Morton
F-18 SiTATE is a promising new PET radiotracer for imaging neuroendocrine tumors.
November 19, 2025
Diagnostic criteria validated in patients with GEP-NETS
By Will Morton
Criteria called SSTR-RADS 1.0 could aid in imaging of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
November 19, 2025
Deep-learning model shows promise in multiple myeloma
By Will Morton
A 3D AI model can improve the efficiency of reading whole-body F-18 FDG-PET/CT images by segmenting lesions on baseline scans.
November 19, 2025
Automated tumor volume assessment validated
By Will Morton
AI-based tumor segmentation using SUV-based thresholds shows high correlation with manual whole-body tumor volume assessments.
November 19, 2025
Page 1 of 2
Next Page